BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15285425)

  • 1. [Tetrahydrobiopterin and endothelial dysfunction].
    Zheng JS; Lin L; Ren J; Chen AF
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):155-8. PubMed ID: 15285425
    [No Abstract]   [Full Text] [Related]  

  • 2. Tetrahydrobiopterin and endothelial function.
    Cosentino F; Lüscher TF
    Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular mechanisms of endothelial cell dysfunction.
    Harrison DG
    J Clin Invest; 1997 Nov; 100(9):2153-7. PubMed ID: 9410891
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrahydrobiopterin: mediator of endothelial protection.
    Katusic ZS; d'Uscio LV
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):397-8. PubMed ID: 15003973
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetic macroangiopathy and NO].
    Hayashi T; Iguchi A
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():548-54. PubMed ID: 15506447
    [No Abstract]   [Full Text] [Related]  

  • 6. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.
    Cai S; Khoo J; Channon KM
    Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase.
    Schoedon G; Schneemann M; Schaffner A
    Circulation; 1995 Aug; 92(4):1060-1. PubMed ID: 7543830
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
    Schmidt TS; Alp NJ
    Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin and eNOS dimer/monomer ratio--a clue to eNOS uncoupling in diabetes?
    Bauersachs J; Schäfer A
    Cardiovasc Res; 2005 Mar; 65(4):768-9. PubMed ID: 15721855
    [No Abstract]   [Full Text] [Related]  

  • 10. [NO and hypertension].
    Hirata Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():243-6. PubMed ID: 15171377
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
    Channon KM
    Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrobiopterin, endothelial nitric oxide synthase, and mitochondrial function in the heart.
    Bauersachs J; Widder JD
    Hypertension; 2009 Jun; 53(6):907-8. PubMed ID: 19398653
    [No Abstract]   [Full Text] [Related]  

  • 14. (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm.
    Mayahi L; Heales S; Owen D; Casas JP; Harris J; MacAllister RJ; Hingorani AD
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1334-9. PubMed ID: 17413035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin.
    Moens AL; Kietadisorn R; Lin JY; Kass D
    J Mol Cell Cardiol; 2011 Oct; 51(4):559-63. PubMed ID: 21458460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension.
    Mitchell BM; Cook LG; Danchuk S; Puschett JB
    Am J Hypertens; 2007 Dec; 20(12):1297-304. PubMed ID: 18047920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of microvascular resistance in physiological conditions and reperfusion.
    DeFily DV
    J Mol Cell Cardiol; 1998 Dec; 30(12):2547-54. PubMed ID: 9990526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A weapon of endothelial cells for fighting vascular disease.
    Tomita N; Komai N
    Hypertens Res; 2010 Feb; 33(2):112-3. PubMed ID: 20057487
    [No Abstract]   [Full Text] [Related]  

  • 19. NO or H(2)O(2) for endothelium-dependent vasorelaxation: Tetrahydrobiopterin makes the difference.
    van Hinsbergh VW
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):719-21. PubMed ID: 11348862
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
    Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
    J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.